Cover Image

A case of Carcinoma Breast with Cerebellar Dysfunction- Paraneoplastic Syndrome

Anand Prasath J .

Abstract


Paraneoplastic Syndrome, as Paraneoplastic   cerebellar degeneration (PCN), in carcinoma breast is a rare entity due to autoimmune response. We report a case report of 52 year female with  carcinoma breast along with           symptoms and signs of cerebellar dysfunction which on          further evaluation is found to be anti-YO autoantibody positive paraneoplastic syndrome. Inspite of surgical and                    chemotherapy patients neurological condition worsened  indicating the poor prognosis of the condition.


Full Text:

PDF

References


Pittock SJ, Kryzer RJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004;56(5):715–9.

Gatti G, Simsek K, Kurne A. Paraneoplastic neurological disorders in breast cancer. Breast. 2003;12:203–7.

Rees JS. Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage J Neurol Neurosurg Psychiatr 75 Suppl 2: ii 43–50

Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, et al. Selective expression of Purkinje-cell antigens in tumour tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med. 1990;322(26):1844–51.

Rojas-Marcos I, Rousseau A, Keime-Guibert F, Rene R, Cartalat-Carel S, Delattre JY, et al. Spectrum of paraneoplastic neurologic disorders in women with breast and gynaecologic cancer. Medicine (Baltimore). 2003;82(3):216–23

Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121(Pt4):561–79.

Storstein A, Vedeler CA. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects. Adv Clin Chem 2007;44:143-85

de Andres C, Esquivel A, de Villoria JG, Graus F, Sanchez-Ramon S. Unusual magnetic resonanc imaging and cerebrospinal fluid findings in paraneoplastic cerebellar degeneration: a sequential study. J Neurol Neurosurg Psychiatry. 2006;77(4):562–3.

Schied R, Voltz R, Briest S, Kluge R, von Cramon DY. Clinical insights into paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry. 2006;77(4):529–30.

Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. A clinical analysis of 55 anti-Yo antibody-positive patients Neurology 1992;42:1931

Posner JB, Dalmau J. Paraneoplastic syndromes. Curr Opin Immunol 1997;9:723-729

Paraneoplastic cerebellar degeneration and dermatomyositis as first manifestations of underlying breast malignancy: a report of two cases and a brief review of the subject Ying Ru Yvonne Ng1*, Chunyin Derek Ho1, Weng Leong Victor Ng2 and Su-Ming Tan1

Rojas I, Graus F, Keime-Guibert F, et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 2000;55:713-715

Furneaux, H.F., Reich, L. and Posner, J.B. (1990) Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40: 1085—1091

Elrington GM, Murray NM, Spiro SG, et al. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry 1991;54:764–7.

Croft P, Wilkinson M. The incidence of carcinomatous neuromyopathy in patients with various types of carcinomas. Brain 1965;88:427–34.

Shams’ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with anti-neuronal antibodies: analysis of 50 patients. Brain 2003;126:1409–18.

Minisini AM, Pauletto G, Bergonzi P, Fasola G. Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini review of the literature. Breast Cancer Res Treat 2007;105:133-136

Miyamoto K, Kato T, Watanabe H, Miyamoto E, Suzuki S. A case of paraneoplastic syndrome accompanied by two types of cancer J Neurol Neurosurg Psychiatry 2002;72:408-409

Darnell RB, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol 2006; 33:270–98.

Silvestre J, Santos L, Batalha V, et al. Paraneoplastic necrotizing myopathy in a woman with breast cancer: a case report J Med Case Reports 2009;3:95.

Storstein A, Vedeler CA. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects. Adv Clin Chem 2007;44:143-85.

Posner JB, Dalmau J. Paraneoplastic syndromes. Curr Opin Immunol 1997;9:723-729.

Rojas I, Graus F, Keime-Guibert F, et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 2000;55:713-715.

Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003;126:1409-1418.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University